« Return to News | Drug Sponsors

Novartis to cut 500 jobs in England

Thursday, March 17, 2011 12:33 PM

Novartis has announced plans to shed some 500 positions in the U.K. through an operational restructuring of its site in Horsham, West Sussex, England, according to PharmaTimes.

Currently, about 950 staff work at the Horsham campus, and that will fall to around 400 over the next two years. Novartis noted that of the workforce, about 330 are dedicated to respiratory research, which will remain in Horsham.

However, Basel, Switzerland-based Novartis said to "further align with global priorities," the gastrointestinal research teams at Horsham will be co-located with teams in Basel and Cambridge over one to two years, while Novartis U.K.'s over-the-counter operations will also move.

Novartis will maintain its major manufacturing sites in Grimsby, Liverpool and Dundee. The company said, "we are collaborating with the government on a number of valuable initiatives to promote life sciences research in the U.K., including Clinical Research Networks, the Academic Health Science Centres and the Therapeutic Capability Clusters."

As for the 500 jobs being lost, Novartis said proposals are currently under consultation and it could not give a final impact on staff numbers. Nevertheless, some observers see the plans as a blow to pharma in the U.K., especially after Pfizer's decision to close its R&D facility in Sandwich, Kent, cutting up to 2,400 jobs.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.